{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T09:40:04Z","timestamp":1739353204640,"version":"3.37.0"},"reference-count":10,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1097\/ftd.0b013e3181b46c1e","type":"journal-article","created":{"date-parts":[[2009,9,22]],"date-time":"2009-09-22T07:18:02Z","timestamp":1253603882000},"page":"602-603","source":"Crossref","is-referenced-by-count":1,"title":["Thalidomide Levels in Patients With Erythema Nodosum Leprosum"],"prefix":"10.1097","volume":"31","author":[{"given":"Jos\u00e9","family":"Luiz Fernandes Vieira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria do Socorro","family":"da Silva Valente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-12-20210129","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/S0140-6736(04)15952-7","article-title":"Leprosy.","volume":"363","author":"Britton","year":"2004","journal-title":"Lancet"},{"key":"R2-12-20210129","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1086\/498216","article-title":"Effective treatment of erythema nodosum leprosum with thalidomide is associated with immune stimulation.","volume":"192","author":"Haslett","year":"2005","journal-title":"J Infect Dis"},{"key":"R3-12-20210129","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S0190-9622(96)90122-X","article-title":"Rediscovering thalidomide: a review of its mechanism of action, side effects, and potential uses.","volume":"35","author":"Tseng","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"R4-12-20210129","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1177\/009127009903901108","article-title":"Single-dose oral pharmacokinetics of three formulations of thalidomide in healthy male volunteers.","volume":"39","author":"Teo","year":"1999","journal-title":"J Clin Pharmacol"},{"key":"R5-12-20210129","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1128\/AAC.41.12.2797","article-title":"Single-dose pharmacokinetics of thalidomide in human immunodeficiency virus-infected patients.","volume":"41","author":"Piscitelli","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"R6-12-20210129","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1021\/js980172i","article-title":"Pharmacokinetics of thalidomide in an elderly prostate cancer population.","volume":"88","author":"Figg","year":"1999","journal-title":"J Pharm Sci"},{"key":"R7-12-20210129","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1211\/0022357001774660","article-title":"Intravenous formulations of the enantiomers of thalidomide: pharmacokinetic and initial pharmacodynamic characterization in man.","volume":"52","author":"Eriksson","year":"2000","journal-title":"J Pharm Pharmacol"},{"key":"R8-12-20210129","doi-asserted-by":"crossref","first-page":"311","DOI":"10.2165\/00003088-200443050-00004","article-title":"Clinical pharmacokinetics of thalidomide.","volume":"43","author":"Teo","year":"2004","journal-title":"Clin Pharmacokinet"},{"key":"R10-12-20210129","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1093\/clinchem\/43.6.1094","article-title":"Handling of blood samples for determination of Thalidomide.","volume":"43","author":"Eriksson","year":"1997","journal-title":"Clin Chem"},{"key":"R11-12-20210129","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/0009-9120(95)00019-6","article-title":"Determination of thalidomide by high performance liquid chromatography: methodological strategy for clinical trials.","volume":"28","author":"Lyon","year":"1995","journal-title":"Clin Biochem"}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0b013e3181b46c1e","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T08:42:14Z","timestamp":1739349734000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007691-200910000-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":10,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0b013e3181b46c1e","relation":{},"ISSN":["0163-4356"],"issn-type":[{"type":"print","value":"0163-4356"}],"subject":[],"published":{"date-parts":[[2009,10]]}}}